Aimovig 140 MG/ML autoinjectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FXUX1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,001
Award facts
- Contract value 100% obligated
- $10,001.16 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,001.16 to AmerisourceBergen Drug Corp for the supply of Aimovig 140 mg/ml auto-injector on January 22, 2026, with an ultimate completion date of January 23, 2026. This competitively awarded, firm fixed-price delivery order was placed under AmerisourceBergen's parent company, Cencora, Inc.'s comprehensive Indefinite Delivery Contract with DLA Troop Support Medical. The IDC, valued at up to $999,999,999.00 and extending through December 31, 2031, serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally. The contract carries no set-aside designation and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania.
Aimovig is a prescription medication used for migraine prevention and represents part of the broader pharmaceutical supply chain that AmerisourceBergen maintains for federal military and veteran healthcare systems. Through its DLA contract vehicle, AmerisourceBergen provides a comprehensive range of medical commodities including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order reflects the company's ongoing role as a critical vendor fulfilling episodic pharmaceutical needs within the Defense Health Agency's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FXUX1?
SPE2DR26FXUX1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 22, 2026.
How much is contract SPE2DR26FXUX1 worth?
The government has obligated $10,001 on SPE2DR26FXUX1.
Is contract SPE2DR26FXUX1 an order under another contract?
Yes. SPE2DR26FXUX1 is a delivery order under SPE2DR25D3004, an indefinite delivery contract.
Was contract SPE2DR26FXUX1 competed?
The extent of competition for SPE2DR26FXUX1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award